Erleada 240 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FEHLY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,352
Award facts
- Contract value 100% obligated
- $7,352.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Erleada 240 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $7,352.49 and utilizes firm fixed price terms, with an ultimate completion date of October 3, 2025. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio with the Defense Logistics Agency demonstrates its capability to supply a wide range of pharmaceuticals across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. This specific delivery order for Erleada, a prostate cancer treatment, exemplifies the specialized pharmaceutical commodities the company routinely provides through its prime vendor agreement with DLA.
Quick answers
Who was awarded contract SPE2DB25FEHLY?
SPE2DB25FEHLY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FEHLY worth?
The government has obligated $7,352 on SPE2DB25FEHLY.
Is contract SPE2DB25FEHLY an order under another contract?
Yes. SPE2DB25FEHLY is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEHLY competed?
The extent of competition for SPE2DB25FEHLY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award